On 16 March 2023, the Federal Joint Committee (G-BA) decided on new detailed regulations for the medical prescription of medical cannabis as a benefit of the statutory health insurance.
On 16 March 2023, the Federal Joint Committee (G-BA) decided on new detailed regulations for the medical prescription of medical cannabis as a benefit of the statutory health insurance.
Since 1 April 2019, new special codes have been in force for the billing of cannabinoids and cannabinoid formulations for pharmacists.